{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "E",
        "alternate": "K",
        "position": 46
      },
      "variant_string_id": "SNCA_E46K",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "reason": "The paper explicitly states that these mutations cause autosomal dominant LBD and affect Î±S aggregation, defining the disease mechanism."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "The assays used (thioflavin S, circular dichroism, EM, AFM) are standard in the field for studying protein aggregation and structure."
        },
        "step_3": {
          "sub_step_3a": {
            "judgment": "No",
            "reason": "The paper does not explicitly mention both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls or multiple replicates."
          },
          "sub_step_3b": {
            "judgment": "Yes",
            "reason": "The assays (e.g., EM, AFM) are broadly accepted techniques in the field."
          },
          "sub_step_3c": {
            "judgment": "No",
            "reason": "The paper does not use known pathogenic/benign variants as controls."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "judgment": "No",
            "reason": "The paper does not provide OddsPath values or explicit statistical analyses (e.g., p-values, effect sizes)."
          },
          "sub_step_4b": {
            "judgment": "Max PS3_supporting / Max BS3_supporting",
            "reason": "The study includes three variants (E46K, A30P, A53T), but the exact number of controls is unspecified."
          }
        },
        "final_evidence_strength": "PS3_supporting",
        "reason": "E46K mutant oligomers are more efficient as fibril seeds than WT, directly supporting pathogenicity."
      }
    },
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "A",
        "alternate": "P",
        "position": 30
      },
      "variant_string_id": "SNCA_A30P",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_3": {
          "sub_step_3a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_3b": {
            "judgment": "Yes",
            "reason": "Same as above."
          },
          "sub_step_3c": {
            "judgment": "No",
            "reason": "Same as above."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_4b": {
            "judgment": "Max PS3_supporting / Max BS3_supporting",
            "reason": "Same as above."
          }
        },
        "final_evidence_strength": "BS3_supporting",
        "reason": "A30P mutant oligomers are less efficient as fibril seeds than WT, suggesting a benign effect."
      }
    },
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "A",
        "alternate": "T",
        "position": 53
      },
      "variant_string_id": "SNCA_A53T",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_3": {
          "sub_step_3a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_3b": {
            "judgment": "Yes",
            "reason": "Same as above."
          },
          "sub_step_3c": {
            "judgment": "No",
            "reason": "Same as above."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_4b": {
            "judgment": "Max PS3_supporting / Max BS3_supporting",
            "reason": "Same as above."
          }
        },
        "final_evidence_strength": "PS3_supporting",
        "reason": "A53T is a well-known pathogenic variant in Parkinson's disease, and its effect on fibril formation aligns with this classification."
      }
    },
    {
      "gene": "SNCA",
      "protein_change": {
        "reference": "A",
        "alternate": "P",
        "position": 30
      },
      "variant_string_id": "SNCA_A30P_A53T",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Same as above."
        },
        "step_3": {
          "sub_step_3a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_3b": {
            "judgment": "Yes",
            "reason": "Same as above."
          },
          "sub_step_3c": {
            "judgment": "No",
            "reason": "Same as above."
          }
        },
        "step_4": {
          "sub_step_4a": {
            "judgment": "No",
            "reason": "Same as above."
          },
          "sub_step_4b": {
            "judgment": "Max PS3_supporting / Max BS3_supporting",
            "reason": "The paper does not provide data on the A30P/A53T double mutant."
          }
        },
        "final_evidence_strength": "Not evaluated",
        "reason": "No data on the double mutant A30P/A53T in the results section."
      }
    }
  ]
}